daz888888888
12-06

$Sunshine Biopharma Inc.(SBFM)$ 

The average one-year price target for Sunshine Biopharma, Inc. is $30.6. The forecasts range from a low of $30.30 to a high of $31.50

A stock’s price target is the price at which analysts consider it fairly valued with respect to its projected earnings and historical earnings. Analysts typically set price targets that correspond to their buy or sell recommendations.

To come up with their price target, an analyst must first determine the stock’s fair value. A common way that analysts calculate the price target for a stock is by creating a multiple of the price-to-earnings ratio. To calculate this, analysts will multiply the market price by the company’s trailing 12-month earnings.

For a company with a 12-month earnings growth rate of 10 percent and a stock that is trading at $30, the multiplier would be 1.10. Based on this information, a possible price target would be:

1.10 x 30 = $33.

Fintel price targets are generated from a collection of forecasts made by different analysts. We provide the high, low, average, and median values for the stock.

Winning Trades
Share your positions with us! This is a column where you can find the winning trades of our fellow tigers. There probably are a few potential opportunities that you may have overlooked.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment